| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,629 |
31,438 |
$1.77M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,865 |
5,421 |
$618K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
6,303 |
4,989 |
$174K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,765 |
2,223 |
$77K |
| 64483 |
|
263 |
223 |
$47K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
480 |
388 |
$33K |
| 64635 |
|
72 |
52 |
$18K |
| 64636 |
|
87 |
64 |
$17K |
| 01938 |
|
164 |
155 |
$13K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
313 |
301 |
$12K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
285 |
37 |
$11K |
| 01992 |
|
111 |
100 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,951 |
3,304 |
$7K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
129 |
51 |
$7K |
| 99152 |
|
455 |
335 |
$7K |
| 62321 |
|
31 |
28 |
$6K |
| 64633 |
|
19 |
16 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
233 |
195 |
$6K |
| 64634 |
|
19 |
16 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
358 |
264 |
$5K |
| 95943 |
|
66 |
58 |
$5K |
| 64484 |
|
67 |
56 |
$4K |
| 93923 |
|
68 |
60 |
$4K |
| 95923 |
|
66 |
58 |
$4K |
| 77002 |
|
48 |
40 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,163 |
4,225 |
$3K |
| 20610 |
|
63 |
52 |
$3K |
| 96136 |
|
110 |
104 |
$3K |
| 01940 |
|
30 |
26 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
220 |
182 |
$3K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
36 |
31 |
$3K |
| 27096 |
|
14 |
14 |
$2K |
| 96103 |
|
285 |
222 |
$2K |
| 99215 |
Prolong outpt/office vis |
17 |
16 |
$2K |
| 96132 |
|
19 |
19 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
231 |
193 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,217 |
2,655 |
$1K |
| 99490 |
Ccm add 20min |
260 |
252 |
$1K |
| 90791 |
Psychiatric diagnostic evaluation |
16 |
15 |
$963.53 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,900 |
2,368 |
$945.00 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
15 |
15 |
$814.18 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
38 |
16 |
$703.17 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
19 |
$661.02 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
25 |
13 |
$529.67 |
| 96130 |
|
16 |
15 |
$480.50 |
| 96127 |
|
222 |
204 |
$381.35 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$315.10 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
826 |
751 |
$308.35 |
| 96138 |
|
19 |
19 |
$241.46 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,883 |
2,326 |
$195.16 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
86 |
69 |
$133.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
324 |
257 |
$99.79 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
343 |
271 |
$22.36 |
| 82570 |
|
589 |
525 |
$0.00 |
| 99408 |
|
51 |
25 |
$0.00 |
| 83992 |
|
588 |
524 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
19 |
14 |
$0.00 |
| 83986 |
|
589 |
525 |
$0.00 |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
55 |
38 |
$0.00 |